FDA Approved: WEZLANA — Original Application (Nuvaila Limited)

View source ↗

Summary

This entry documents the original Biologics License Application for WEZLANA, a ustekinumab-AUUB monoclonal antibody developed by Nuvaila Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• WEZLANA (USTEKINUMAB-AUUB)

Snippet

ORIG AP for WEZLANA (USTEKINUMAB-AUUB)